Biomarkers for early detection and screening in pancreatic cancer. Highlights from the 45th ASCO annual meeting. Orlando, FL, USA. May 29-June 2, 2009
- PMID: 19581733
Biomarkers for early detection and screening in pancreatic cancer. Highlights from the 45th ASCO annual meeting. Orlando, FL, USA. May 29-June 2, 2009
Abstract
Pancreatic cancer is the second most frequent gastrointestinal malignancy with an unabated mortality that reflects the advanced stage of presentation. Detection of early disease through screening likely is the best way to meaningfully prolong survival. The development of biomarkers for screening holds enormous promise for increasing early detection and impacting mortality. Many biomarkers have been studied including the serum protein carbohydrate antigen 19-9, vascular endothelial growth factor, and nuclear factor kappa B, however, still no blood test or other fluid analysis reliably predicts patients with disease. The authors review abstracts from the 2009 annual meeting of the American Society of Clinical Oncology, Orlando, FL, U.S.A., that report evidence for early detection using a salivary biomarker array (#4630); a mucin epitope to PAM4 (#4613); a plasma nucleotide marker of hypoxia, miR-210 (#4624); and a cleavage product of complement pathway component C3b, iC3b (#4626). The meeting featured pancreatic cancer in over 100 research abstracts, of which, four are reviewed that focus on potential markers for early detection. When applied to a population of high risk patients, biomarkers of early pancreatic cancer could provide a minimally invasive way of identifying patients that require further evaluation using endoscopic tools. These molecular beacons may even be found to be sufficiently sensitive, specific, and cost effective to be applied to a broader population of patients.
Similar articles
-
Early detection and screening of pancreatic cancer. Highlights from the "2011 ASCO Gastrointestinal Cancers Symposium". San Francisco, CA, USA. January 20-22, 2011.JOP. 2011 Mar 9;12(2):83-5. JOP. 2011. PMID: 21386626
-
Methods and rationale for the early detection of pancreatic cancer. Highlights from the "2010 ASCO Gastrointestinal Cancers Symposium". Orlando, FL, USA. January 22-24, 2010.JOP. 2010 Mar 5;11(2):128-30. JOP. 2010. PMID: 20208319 Review.
-
Screening for early pancreatic ductal adenocarcinoma: an urgent call!JOP. 2009 Mar 9;10(2):104-8. JOP. 2009. PMID: 19287101
-
New developments in the treatment of locally advanced pancreatic cancer. Highlights from the 45th ASCO annual meeting. Orlando, FL, USA. May 29-June 2, 2009.JOP. 2009 Jul 6;10(4):366-72. JOP. 2009. PMID: 19581736
-
Biomarkers and pharmacogenetics in pancreatic cancer. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011.JOP. 2011 Jul 8;12(4):325-9. JOP. 2011. PMID: 21737888 Review.
Cited by
-
Metabolomics based predictive classifier for early detection of pancreatic ductal adenocarcinoma.Oncotarget. 2018 May 1;9(33):23078-23090. doi: 10.18632/oncotarget.25212. eCollection 2018 May 1. Oncotarget. 2018. PMID: 29796173 Free PMC article.
-
Diagnostic value of combining CA 19-9 and K-ras gene mutation in pancreatic carcinoma: a meta-analysis.Int J Clin Exp Med. 2014 Oct 15;7(10):3225-34. eCollection 2014. Int J Clin Exp Med. 2014. PMID: 25419353 Free PMC article.
-
Secretome-based identification of ULBP2 as a novel serum marker for pancreatic cancer detection.PLoS One. 2011;6(5):e20029. doi: 10.1371/journal.pone.0020029. Epub 2011 May 20. PLoS One. 2011. PMID: 21625447 Free PMC article.
-
Identification of novel pancreatic adenocarcinoma cell-surface targets by gene expression profiling and tissue microarray.Biochem Pharmacol. 2010 Sep 1;80(5):748-54. doi: 10.1016/j.bcp.2010.05.018. Epub 2010 May 25. Biochem Pharmacol. 2010. PMID: 20510208 Free PMC article.
-
Salivary transcriptomic biomarkers for detection of resectable pancreatic cancer.Gastroenterology. 2010 Mar;138(3):949-57.e1-7. doi: 10.1053/j.gastro.2009.11.010. Epub 2009 Nov 18. Gastroenterology. 2010. PMID: 19931263 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical